Nicotine Skin Patches |
Habitrol; NicoDerm; Nicotine transdermal system; Nicotrol; ProStep |
Clinical Trial: Timing of Smoking Intervention in Alcohol Treatment (nicotine patch)
This study is no longer recruiting patients.
|
Purpose
This study will attempt to determine the best time to begin a smoking cessation program in individuals who undergo intensive treatment for alcohol dependence. The goal of this trial is to determine whether a smoking cessation program is more effective if it occurs at the same time as or after treatment for alcohol dependence. The study also will attempt to determine the effect of smoking cessation programs on the outcome of treatment for alcohol dependence.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Alcoholism Smoking | Drug: nicotine replacement patch | Phase IV |
MedlinePlus related topics: Alcoholism; Smoking
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Efficacy Study
Official Title: Timing of Smoking Intervention in Alcohol Treatment
Expected Total Enrollment: 500
Study completion: September 2002
Eligibility
Ages Eligible for Study: 21 Years - 75 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Meets criteria for alcohol use disorder and other drug dependence.
- Complete first week of alcohol treatment program.
- Current cigarette smoker (more than 5 cigarettes/day, smoking more than 1 year).
Exclusion Criteria:
- Lifetime diagnosis of an excluding psychiatric disorder: bipolar disorder, schizophrenia or other psychotic disorder, panic disorder with or without agoraphobia, obsessive-compulsive disorder, generalized anxiety disorder, eating disorder, post- traumatic stress disorder, antisocial personality disorder, or borderline personality disorder.
- Unable to participate in protocol due to functional deficits or severe depression.
- Suicidal or homicidal ideation.
- Current use of disulfiram (Antabuse) or naltrexone (Revia).
- Current use of pipes, cigars, or smokeless tobacco and unwillingness to stop.
- Lives more than 100 miles from alcohol treatment facility.
- No telephone.
Location Information
Minnesota
General Internal Medicine, VA Medical Center, Minneapolis, Minnesota, 55417, United States
More Information
Record last reviewed: November 2004
Last Updated: November 15, 2004
Record first received: November 2, 1999
ClinicalTrials.gov Identifier: NCT00000444
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -

